1 2 3 4 5
читать далее ... y of gemcitabine in advanced cholangiocarcinoma and gallbladder carcinoma Proc. ASCO 2005 4230 15. R. Dobrilla-Dintinjana, I. Djipalo, D. Stimac e.a. Chemotherapy in patients with nonresectable cancer of the biliary system of advanced gallbladder cancer: Do elderly have benefit of all Proc ASCO 2005 4268 16. N. Gebbia, F. Verderame, R.Di Leo e.a. A phase II study of oxaliplatin and gemcilabine first line chemotherapy in patients with advanced biliary tract cancers. Proc ASCO 2005 4132 17. J.O. Park, W.K. Kang, T.Y. Kirn e.a. A phase II trial of gemcitabine plus cisplatin in patients with inoperable biliary tract cancer. Proc ASCO 2005 4133 18. H.M. Chang, M.H. Ryu, J.L. Lee e.a. Phase II trial ofgemcitabine plus capecitabine in patients with advanced biliary tract cancer. Proc ASCO 2005 4173 19. R.Ahmed, В. Barman, R.Chosh e.a. Combination of gemcitabine and cisplatin chemotherapy in unresectable gallbladder cancer Eur.J.Canc. v3, 2, 2005 p220, 771 20. Korner G.V., Schuell В., Laengle F. e.a. Mitomycin С in combination with capecitabin or biweekly high-dose gemcitabin in patients with advanced biliary tract cancer: a randomized phase II trial Ann Oncol.2004, vl5, D478-483 21. G. Jorge, R. Betzabe, B. Olga e.a. Treatment of advanced gallbladder cancer with gemcitabine or gemcitabine-cisplatin. Eur.J.Canc. v3, 2, 2005, p220, 772 22. 0. Nehls, H. Oettle, J.T. Hartmann e.a. A prospective multicenter phase II trials of capecitabine plus oxaliplatin (CAPOX) in advanced biliary system adenocarcinomas: The final results J. of Clin. Oncol v24, pi, 2006, p221s4136 23. S.H. Park, S.I. Lee, S.H. Han e.a. Epirubicin, cisplatin and capecitabine for advanced biliary tract adenocarcinoma: a phase II study. Eur.J.Canc. v3, 2, 2005, p221, 774 24. J. Feisthammel, К. Schoppmeyer, M. Wiedmann e.a. Irinotecan with 5 FU/FA in advanced biliary tract adenocarcinomas - a multicenter phase II trial. Proc. Asco 2005, 4179 25. K.Y. Glover, M.B. Thomas, T.D. Brown e.a. A phase II study of oxaliplatin and capecitabine (XELOX) in patients with unresectable cholangiocarcinoma, including biliary tract. Proc. ASCO 2005,4123 26. К. Uchida, К. Hayashi, M. Yamamota e.a. High response rates in patients with advanced biliary tract cancer using the oral fluoropyrimidine S-1 Proc. ASCO 2005, 4239 27. J. Harder, B.Riecren, 0. Kummer e.a. Out patient chemotherapy with gemcitabine and oxaliplatin advanced biliary tract cancer: a phase II study. J. Clin. Oncol. V24. p I 2006, 14006 28. J.L, BibI, F.C. Lee, M. Roach e.a. Capecitabine, irinotecan and eclocoxib for patients with unresectable/metastatic cholangiocarcinoma. Proc. ASCO 2005, 4265 29. B.Paule, M.Bralet, M.Herelle e.a. Cetuximab plus gemcitabine/oxaliplatin (GEMOX) for patients with unresectable/recurrent intrahepatic cholangiocarcinoma refractory to GEMOX. J. Clin. Oncol. V 24 pi 2006 14084 30. R. К. Ramanathan, C.P. Belani, D.A. Singh e.a. Phase II study of lapatinib a dual inhibitor Of EGFR tyrosine kinase 1 and 2 in patients witИсточник: Орел Н.Ф. Русский медицинский журнал. 2006. Т.14. №14. С.1053-1056